HAC (Russian)
RSCI (Russian)
EBSCO
DOI (USA)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

RADIATION THERAPY IN THE TREATMENT OF NON-SMALL-CELL LUNG CANCER

Download full text PDF
Issue: 
2
Year: 
2016

D. Gogolin; Professor I. Gulidov, MD; Yu. Ragulin, Candidate of Medical Sciences A.F. Tsyb Medical Radiology Research Center, Branch, National Medical RadiologyResearch Center, Ministry of Health of the Russian Federation, Obninsk

The paper considers the importance of radiotherapy in the combination treatment of patients with non-small-cell lung cancer (NSCLC). It describes different radiotherapy options and possibilities of combined treatments in patients with NSCLC.

Keywords: 
radiation therapy
non-small-cell lung cancer



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx .
  2. Davydov M.I., Aksel' E.M. Statistika zlokachestvennyh novoobrazova nij v Rossii i stranah SNG v 2010 g. / M.: RONTs, 2012.
  3. Zlokachestvennye novoobrazovanija v Rossii v 2013 godu. Pod red. A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoj / M.: MNIOI im. P.A. Gertsena – filial FGBU «FMITs im. P.A. Gertsena» Minzdrava Rossii, 2015; 250 s.
  4. Review on the tolerance of normal tissue to the therapeutic radiation // Int. J. Radiat. Oncol. Biol. Phys. – 2010; 76 (3): 1–120
  5. Bral S., Gevaert T., Linthout N. et al. Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of Phase II trial // Int. J. Rad. Oncol. Biol. Phys. – 2011; 80: 1314–49.
  6. Sashendra S., Haasbeek C., Slotman B. et al. Outcomes of stereotactic ablative radiotherapy for central lung tumors: A systematic review // Radioth. Oncol. – 2013; 106: 276–82.
  7. Bojko A.V., Chernichenko A.V., Mescherjakova I.A. i dr. Luchevaja terapija nemelkokletochnogo raka // Prakt. onkol. – 2000; 3: 24–8.
  8. Cerfolio R., Bryant A., Cerfolio R. Pulmonary resection after concurrent chemotherapy and high dose (60 Gy) radiation for non-small cell lung cancer is safe and may provide increased survival // Eur. J. Cardiothorac. Surg. – 2009; 35 (4): 718–23.
  9. Kwong K., Edelman M., Suntharalingam M. et all. High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival // J. Thorac. Cardiovasc. Surg. – 2005; 129 (6): 1250–7.
  10. Vorob'ev A.V., Zav'jalov A.A., Dobrodeev A.Ju. i dr. Kombinirovannoe lechenie raka legkogo III stadiej s intraoperatsionnoj luchevoj terapiej i radiosensibilizatsiej // Sib. onkol. zhurn. – 2009; Pril. 1: 75–6.
  11. Bradley J., Paulus R., Graham M. et al. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group – RTOG 9705 // J. Clin. Oncol. – 2005; 23 (15): 3480–7.
  12. Auperin A., Rolland E., Curran W. et al. Concomitant radiochemotherapy (RT-CT) versus sequential RT-CT in locally advanced non-small cell lung cancer (NSCLC): A meta-analysis using individual patient data (IPD) from randomized clinical trials (RCTs) // J. Thorac. Oncol. – 2007; 2: 310.
  13. Belderbos J., Uitterhoeve L., Belderbos H. et al. Randomised trial of . sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973) // Eur. J. Cancer. – 2007; 43: 114–21.
  14. Saunders M., Dische S., Barrett A. et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial // Radioth. Oncol. – 1999; 52: 137–48.
  15. Belani C., Wang W., Johnson D. et al. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer // J. Clinic. Oncol. – 2005; 23 (16): 3760–7.
  16. Jeremic B., Milicic B., Milisavljevic S. Clinical prognostic factors in patients with locally advanced (stage III) non-small cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 patients // Cancer. – 2011; 117: 2995–3003.
  17. Nemkova E.V., Muss V.F. Luchevaja terapija raka legkogo s ispol'zovani metodiki netraditsionnogo fraktsionirovanija i radiomodifikatsii. Materialy Nevskogo radiologicheskogo foruma «Nevskie gorizonty» / SPb, 2007; s. 680.
  18. Il'in M.A., Sotnikov V.M., Pan'shin G.A. i dr. Rezul'taty luchevoj terapii nemelkokletochnogo raka legkogo srednimi fraktsijami. Materialy IV Vseross. nats. kongressa luchevyh diagnostov i terapevtov «Radiologija-2010», 2010; s. 176.
  19. Gogolin D.V., Gulidov I.A., Mardynskij Ju.S. i dr. Uskorennoe giperf raktsionirovanie s neravnomernym drobleniem dnevnoj dozy pri luchevom i himioluchevom lechenii neoperabel'nogo nemelkokletochnogo raka legkogo // Sib. onkol. zhurn. – 2014; 6: 5–9.